Sign in →

Test Code LAB1386 Myotonic Dystrophy Type 1 Repeat Expansion Analysis

Clinical System Name

Myotonic Dystrophy Type 1 Repeat Expansion Analysis

Synonyms

Myotonic Dystrophy Type 1

DM1

DMPK
 

Sample Requirements

Preferred Specimen: Whole Blood

Container(s): Lavender Top Tube, Lavender Microtainer

Preferred Vol: 5.0 mL

Minimum Vol: 3.0 mL

 

Alternative Specimen: DNA

Container(s): Sterile Plastic Tube

Preferred Vol: 15 ug, concentration: 50 ng/ul

Minimum Vol:

 

 

Alternative Specimen: Swab

Container(s): Buccal Swab

Preferred Vol: 1 Buccal Swab

Minimum Vol: 1 Buccal Swab

 

Alternative Specimen: Saliva

Container(s): Saliva Kit

Preferred Vol: 1 Saliva Kit

Minimum Vol: 1 Saliva Kit

Processing Instructions

Reject due to:

Spin: N

Aliquot: N

Temp: RT

Storage location: Affix large Epic labels to tubes and place in room temperature Send Outs rack.

 

Off-site collection: Send whole blood refrigerated.

Stability

Specimen Type Temperature Time
Whole Blood Room temp 3 d
Whole Blood Refrigerated 7 d
Whole Blood Frozen N
Extracted DNA Room temp 3-4 d
Extracted DNA Refrigerated 1 y
Extracted DNA Frozen Indefinitely

 

Availability

STAT TAT
No 21 days

 

Performing Laboratory

Baylor College of Medicine

Baylor Genetics Laboratories

2450 Holcombe - Grand Blvd Dock

Houston, TX 77021-2024

 

Phone: (800) 411-4363

 

Department

Department: Send Outs/Genetic

Phone Number: (206) 987-2563

Methodology

Method: PCR-amplification, Southern Blot with densitometry

Analytical Volume:

Limitations:

Reference Range

DMPK alleles with >49 repeats are abnormal; alleles with <35 repeats are normal. individuals with 35-49 repeats (premutation alleles) do not have symptoms but their children are at increased risk of inheriting larger repeats and having symptoms.

Send Out Instructions

Reference Lab Test Name: Myotonic Dystrophy Type 1 Repeat Expansion Analysis
Reference Lab Test Number: 6041
Instructions: Ship at room temperature, avoid freezing sample. Send overnight via FedEx.

 

Description

The Myotonic Dystrophy Type 1 Repeat Expansion Analysis is performed to determine the number of CTG repeats in the DMPK gene.

 

Myotonic dystrophy type 1 is one of a group of muscular dystrophies and is the most common adult muscular dystrophy. The onset of symptoms is variable and ranges from congenital to adulthood. The congenital form typically presents with hypotonia, severe intellectual disability, and potentially lethal respiratory distress. In older individuals, the characteristic findings include progressive weakness, muscle wasting, myotonia, and cataracts; in males, frontal balding and testicular atrophy are common. Premutation carriers of myotonic dystrophy may be at risk for cardiac irregularities.

 

Unaffected: 5-34 repeats
Premutation carrier: 35-49 repeats
Full mutation, myotonic dystrophy: ≥ 50 repeats

 

Pregnancies with congenital myotonic dystrophy often show decreased fetal movement, talipes, and severe polyhydramnios on ultrasonography; diagnostic testing for myotonic dystrophy and/or carrier screening for the pregnant individual should be considered (1,2).

 

References:
1. Zaki M, Boyd PA, Impey L, Roberts A, Chamberlain P. Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome. Ultrasound Obstet Gynecol. 2007 Mar;29(3):284-8. doi: 10.1002/uog.3859. PMID: 17238150.
2. Yee C, Choi SJ, Oh SY, Ki CS, Roh CR, Kim JH. Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy. Obstet Gynecol Sci. 2017 Jul;60(4):323-328. doi: 10.5468/ogs.2017.60.4.323. Epub 2017 Jul 14. PMID: 28791262; PMCID: PMC5547078.

Clinical Utility

Indications for testing include:
- Confirm a clinical diagnosis of myotonic dystrophy
- Evaluate suspected myotonic dystrophy
- Presymptomatic testing of adults at-risk for myotonic dystrophy (in conjunction with genetic counseling)
- Prenatal diagnosis of an at-risk pregnancy
- Differential diagnosis of neonates with unexplained hypotonia and/or respiratory distress